Facebook Twitter YouTube Google Plus

K.) New Developments in Radiation Oncology: A Global Perspective

Malcolm Feigen, MD
Heidelberg Reparation Hospital, Australia

Dr. Malcolm Feigen radiation oncologist working in Melbourne, Australia who began using high dose radiotherapy to palliate mesothelioma patients in 2003 after meeting Dr Craig Stevens from MD Anderson Cancer Center. As the thoracic surgeons at his institution were reluctant to perform pneumonectomies, he began using radiotherapy to delay recurrences after pleurectomy/decortications with photodynamic therapy in patients who were not given chemotherapy, and performed PET/CT scans to define the active disease regions before planning their radiotherapy. Many patients returned for follow up PET scans and, as few experienced radiotherapy complications, he gradually expanded the treatment field using more advanced radiotherapy technologies, and is currently offering intensity-modulated radiotherapy to the whole hemithorax in selected patients with advanced mesotheliomas who have not had the involved lung removed. There have been no significant toxicities with doses up to 60 Gy in six weeks, and PET scans performed up to five years after radiotherapy have shown long term local control.

Kenneth Rosenzweig, MD
Memorial Sloan-Kettering Cancer Center

Dr. Kenneth Rosenzweig is a radiation oncologist at Memorial Sloan-Kettering Cancer Center with clinical expertise in treating cancers of the chest: non-small cell lung cancer, small cell lung cancer, mesothelioma, and thymoma. His research involves adapting the latest technology to allow for safer, more aggressive radiation therapy for lung cancer.

Click here to view the slides for "New Developments in Radiation Oncology: A Global Perspective", by Malcolm Feigen, MD and Ken Rosenzweig, MD.

To view this video presentation, please click on the image below.

© 2009 Mesothelioma Applied Research Foundation, Inc. All rights reserved. 501(c)(3)

A.) Effective Advocacy and the Case for Federal Meso Research Funding

B.) State Assistance on Insurance Appeals

C.) Cancer Genetics in the Mesothelioma Family

D.) Fundraising

E.) Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

F.) Update from Across the Pond

G.) The Mesothelioma Experience: Patient and Provider Perspectives Panel

H.) Work of the Science Advisory Board

J.) Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective

K.) New Developments in Radiation Oncology: A Global Perspective

M.) Pain Management

Mesothelioma Treatment: Present & Future from a Surgeon & Research Perspective | Dr. Harvey Pass

N.) Traditional Healing with Modern Science

O.) Update on Clinical Trials and Mesothelioma Research

P.) Mesothelioma Tissue Bank

Photodynamic Therapy for Mesothelioma Treatment | Dr. Joseph Friedberg

Q.) EGFR Inhibitors for Patients with Malignant Peritoneal Mesothelioma

R.) The Use of Cytokine Inhibitors: Translational Lab Results

S.) Identifying and Targeting Aggressive Malignant Peritoneal Mesothelioma: Morphologic and Molecular Studies

T.) Treatment Options for Patients with Recurrent Disease after HIPEC, HRA - Panel Discussion